ImmunityBio, Inc. (IBRX)

ImmunityBio Revenue

ImmunityBio had revenue of $32.06M in the quarter ending September 30, 2025, with 425.07% growth. This brings the company's revenue in the last twelve months to $82.56M, up 1,025.95% year-over-year. In the year 2024, ImmunityBio had annual revenue of $14.75M with 2,270.58% growth.

• Revenue (ttm): $82.56M
• Revenue Growth: +1,025.95%
• P/S Ratio: 22.28
• Revenue / Employee: $121,404
• Employees: 680
• Market Cap: 2.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.75M	14.12M	2,270.58%
Dec 31, 2023	622.00K	382.00K	159.17%
Dec 31, 2022	240.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-